Who Owns Champions Oncology Stock?
NASDAQ: CSBRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 48.71%
- Held by insiders
- 26.33%
- Institutional holders
- 35
- Institutions 48.7%
- Insiders 26.3%
- Public and other 25.0%
Who owns Champions Oncology stock?
Institutional investors own about 48.7% of Champions Oncology's shares, spread across 35 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 26.33% of CSBR.
The largest institutional holders are Battery Management Corp. (17.40%), NEA Management Company, LLC (12.31%) and Vanguard Capital Management LLC (2.17%). Together, the top 10 institutions control 40.5% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their CSBR positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CSBR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Battery Management Corp. | 2.42M | 17.40% | 0.0% |
| NEA Management Company, LLC | 1.71M | 12.31% | 0.0% |
| Vanguard Capital Management LLC | 301.35K | 2.17% | +0.6% |
| Tocqueville Asset Management L.p. | 295.66K | 2.12% | -7.5% |
| Morgan Stanley | 235.40K | 1.69% | -2.9% |
| Bank of America Corporation | 214.06K | 1.54% | +880.4% |
| Renaissance Technologies, LLC | 139.04K | 1.00% | -4.5% |
| Blackrock Inc. | 129.85K | 0.93% | +4.8% |
| Mink Brook Asset Management LLC | 111.34K | 0.80% | 0.0% |
| Geode Capital Management, LLC | 76.30K | 0.55% | -1.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CSBR
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 229.97K | 1.65% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 62.77K | 0.45% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 31.22K | 0.22% |
| iShares Trust-iShares Micro-Cap ETF | 28.27K | 0.20% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 12.14K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 10.96K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 9.23K | 0.07% |
| SCHWAB CAPITAL TRUST-Schwab Total Stock Market Index Fund | 6.85K | 0.05% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 6.53K | 0.05% |
| Northern Funds-SMALL CAP CORE FUND | 4.47K | 0.03% |
Frequently asked questions
Who is the largest shareholder of Champions Oncology?
Battery Management Corp. is the largest institutional shareholder of CSBR, owning 17.40% of shares outstanding (2.42M shares) as of its latest 13F filing.
What percentage of Champions Oncology is owned by institutions?
Institutions own about 48.7% of CSBR shares and 66.1% of the public float.
How much of Champions Oncology do insiders own?
Insiders, such as officers and directors, own about 26.33% of CSBR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.